HOME > TOP STORIES
TOP STORIES
-
ORGANIZATION Industry Group Poised for Pilot Rollout of E-Labeling App in April, Looks to Sales Reps for Popularization
March 26, 2021
-
BUSINESS Astellas Sees Growth Potential for “Rx+” as Future Bread-and-Butter Biz: EVP
March 26, 2021
-
REGULATORY Chuikyo OKs Appraisal Results for Kymriah, Trelegy; Downward Price Tweaks Expected
March 25, 2021
-
REGULATORY Nichi-Iko Plant Probed before Lifting of Biz Suspension Order
March 25, 2021
-
REGULATORY Japan Approves Incyte’s Pemazyre, Bayer’s Vitrakvi, Novartis’ Kesimpta, and More
March 24, 2021
-
REGULATORY Appraisal Results for Kymriah, Trelegy Up for Chuikyo Review on March 24; Price Cuts Likely
March 23, 2021
-
BUSINESS Japan Approves 3rd CAR-T Cell Therapy, Celgene’s Breyanzi
March 23, 2021
-
ORGANIZATION Japan Govt Should Change Course on Consistent Price Cuts for On-Patent Drugs: FPMAJ Exec
March 22, 2021
-
BUSINESS Takeda’s OTC Unit to Be Renamed Alinamin with New Chief from Blackstone
March 22, 2021
-
REGULATORY MHLW to Set Up Medical Supply Office in April after COVID-19, Antibiotic Shortage
March 19, 2021
-
ORGANIZATION Trade Groups Push Proper Pricing of Innovative Drugs to Restore Attractiveness of Japan: LDP Confab
March 19, 2021
-
ORGANIZATION With Aducanumab in Mind, Outgoing Chuikyo Payer Rep Floats Rule to Reward Cost Cuts for Pricey Meds
March 18, 2021
-
BUSINESS Morimoto Pharma Looking to Partner with Drug Makers, CMOs to Develop Freeze-Dried COVID Vaccines in Japan
March 17, 2021
-
BUSINESS Quake-Halted Nipro Plant Affecting Supplies of Pfizer, Espha Generics
March 17, 2021
-
BUSINESS Alesion Dry Syrup, Generics Pulled from Shelves over Mutagenic Impurities
March 16, 2021
-
BUSINESS Takeda Appoints Milano Furuta as New Japan Chief
March 16, 2021
-
ACADEMIA Tokushukai Weighs Switches from Nichi-Iko Products after Biz Suspension Order
March 15, 2021
-
BUSINESS Me Pharma Eyes Production of 1 Billion Tablets in FY2021, Sales Buoyed by Low Prices
March 12, 2021
-
BUSINESS JMA Affiliate Data Operator Poised to Provide RWD from NHO Hospitals to Drug Makers
March 11, 2021
-
BUSINESS Takeda to Buy Out T-Cell Engager Specialist Maverick for US$525 Million
March 11, 2021
ページ
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
